CYP cynata therapeutics limited

Ann: First Patient Treated in Phase 2 GvHD Trial, page-8

  1. 4,414 Posts.
    lightbulb Created with Sketch. 1570
    Hi Pledge,

    CYP management, have secured FDA approval, to run the trial in for aGVHD, as per the announcement and reported on Hot Copper.

    https://hotcopper.com.au/data/attachments/6014/6014093-14d780fd5de5a1e4ac79a00d14e82076.jpg
    Not like your beloved company, after 10 years, of trying haven't received any approval for anything, but taking those share holders for a ride to No Where.

    That why they are talking about class action against the company.

    IMHO.

    Regards

    Rossi70
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.0¢
Change
-0.005(3.03%)
Mkt cap ! $36.15M
Open High Low Value Volume
16.5¢ 16.5¢ 16.0¢ $73.23K 457.5K

Buyers (Bids)

No. Vol. Price($)
1 31250 16.0¢
 

Sellers (Offers)

Price($) Vol. No.
16.5¢ 27550 2
View Market Depth
Last trade - 16.10pm 23/06/2025 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.